Pure Global

Prospective Evaluation of the Use of PET-CT in Hepatocarcinoma - Trial RBR-3vxgjsj

Access comprehensive clinical trial information for RBR-3vxgjsj through Pure Global AI's free database. This phase not specified trial is sponsored by Fundação Antônio Prudente - AC Camargo Cancer Center and is currently Recruiting. The study focuses on Hepatocellular carcinoma.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Registro Brasileiro De Ensaios Clinicos data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
RBR-3vxgjsj
Recruiting
Trial Details
Registro Brasileiro De Ensaios ClinicosRBR-3vxgjsj
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Prospective Evaluation of the Use of PET-CT in Hepatocarcinoma
Prospective Evaluation of the Use of PET-CT with 18 F -PSMA in Hepatocarcinoma: Comparison With Conventional Morphological Methods and Impact on Management Change

Study Focus

Hepatocellular carcinoma

Observational

Sponsor & Location

Fundação Antônio Prudente - AC Camargo Cancer Center

Brazil

Timeline & Enrollment

N/A

Jan 01, 2023

N/A

ICD-10 Classifications

Malignant neoplasm: Hepatoblastoma
Malignant neoplasm: Liver cell carcinoma
Malignant neoplasm: Other specified carcinomas of liver
Malignant neoplasm: Liver, unspecified
Malignant neoplasm: Hepatic flexure

Data Source

Registro Brasileiro De Ensaios Clinicos

RBR-3vxgjsj

Non-Device Trial